1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine

C119H146N30O15 — CID 157052115

IUPAC1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine
SMILESCOc1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nn1.Cc1cc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n[nH]1.Cc1cc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nn1C.Cn1ccc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.c1cnc2c(OC3CCC(Nc4ncc(C5CCOC5)cn4)CC3)cc(N3CCOCC3)cc2n1
InChIInChI=1S/C26H32N6O3.C24H30N6O3.3C23H28N6O3/c1-3-22(4-2-20(1)31-26-29-15-19(16-30-26)18-5-10-34-17-18)35-24-14-21(32-8-11-33-12-9-32)13-23-25(24)28-7-6-27-23;1-16-13-21(28-29(16)2)24(31)27-17-3-5-19(6-4-17)33-22-15-18(30-9-11-32-12-10-30)14-20-23(22)26-8-7-25-20;1-28-9-6-19(27-28)23(30)26-16-2-4-18(5-3-16)32-21-15-17(29-10-12-31-13-11-29)14-20-22(21)25-8-7-24-20;1-15-12-20(28-27-15)23(30)26-16-2-4-18(5-3-16)32-21-14-17(29-8-10-31-11-9-29)13-19-22(21)25-7-6-24-19;1-30-22-7-6-21(27-28-22)26-16-2-4-18(5-3-16)32-20-15-17(29-10-12-31-13-11-29)14-19-23(20)25-9-8-24-19/h6-7,13-16,18,20,22H,1-5,8-12,17H2,(H,29,30,31);7-8,13-15,17,19H,3-6,9-12H2,1-2H3,(H,27,31);6-9,14-16,18H,2-5,10-13H2,1H3,(H,26,30);6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,26,30)(H,27,28);6-9,14-16,18H,2-5,10-13H2,1H3,(H,26,27)
InChIKeyAAIDXELWKBRNEC-UHFFFAOYSA-N
MW2236.67 g/mol
LogP14.20
Rot. Bonds27

About 1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine

1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine (PubChem CID 157052115) has the molecular formula C119H146N30O15 and a molecular weight of 2236.67 g/mol. Its IUPAC name is 1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine.

Molecular Properties

Compound Name1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine
PubChem CID157052115
Molecular FormulaC119H146N30O15
Molecular Weight2236.67 g/mol
Exact Mass2235.16
IUPAC Name1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine
SMILESCOc1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nn1.Cc1cc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n[nH]1.Cc1cc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nn1C.Cn1ccc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.c1cnc2c(OC3CCC(Nc4ncc(C5CCOC5)cn4)CC3)cc(N3CCOCC3)cc2n1
InChIInChI=1S/C26H32N6O3.C24H30N6O3.3C23H28N6O3/c1-3-22(4-2-20(1)31-26-29-15-19(16-30-26)18-5-10-34-17-18)35-24-14-21(32-8-11-33-12-9-32)13-23-25(24)28-7-6-27-23;1-16-13-21(28-29(16)2)24(31)27-17-3-5-19(6-4-17)33-22-15-18(30-9-11-32-12-10-30)14-20-23(22)26-8-7-25-20;1-28-9-6-19(27-28)23(30)26-16-2-4-18(5-3-16)32-21-15-17(29-10-12-31-13-11-29)14-20-22(21)25-8-7-24-20;1-15-12-20(28-27-15)23(30)26-16-2-4-18(5-3-16)32-21-14-17(29-8-10-31-11-9-29)13-19-22(21)25-7-6-24-19;1-30-22-7-6-21(27-28-22)26-16-2-4-18(5-3-16)32-20-15-17(29-10-12-31-13-11-29)14-19-23(20)25-9-8-24-19/h6-7,13-16,18,20,22H,1-5,8-12,17H2,(H,29,30,31);7-8,13-15,17,19H,3-6,9-12H2,1-2H3,(H,27,31);6-9,14-16,18H,2-5,10-13H2,1H3,(H,26,30);6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,26,30)(H,27,28);6-9,14-16,18H,2-5,10-13H2,1H3,(H,26,27)
InChIKeyAAIDXELWKBRNEC-UHFFFAOYSA-N
XLogP14.20
TPSA483.10 Ų
H-Bond Donors6
H-Bond Acceptors41
Rotatable Bonds27
Heavy Atoms164
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002236.67
LogP ≤ 514.20
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1041

Analyze 1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine?
The IUPAC name of 1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine (CID 157052115) is 1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine.
What is the SMILES notation for 1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine?
The canonical SMILES for 1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine is COc1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nn1.Cc1cc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n[nH]1.Cc1cc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nn1C.Cn1ccc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.c1cnc2c(OC3CCC(Nc4ncc(C5CCOC5)cn4)CC3)cc(N3CCOCC3)cc2n1.
What is the InChIKey of 1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine?
The InChIKey is AAIDXELWKBRNEC-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H32N6O3.C24H30N6O3.3C23H28N6O3/c1-3-22(4-2-20(1)31-26-29-15-19(16-30-26)18-5-10-34-17-18)35-24-14-21(32-8-11-33-12-9-32)13-23-25(24)28-7-6-27-23;1-16-13-21(28-29(16)2)24(31)27-17-3-5-19(6-4-17)33-22-15-18(30-9-11-32-12-10-30)14-20-23(22)26-8-7-25-20;1-28-9-6-19(27-28)23(30)26-16-2-4-18(5-3-16)32-21-15-17(29-10-12-31-13-11-29)14-20-22(21)25-8-7-24-20;1-15-12-20(28-27-15)23(30)26-16-2-4-18(5-3-16)32-21-14-17(29-8-10-31-11-9-29)13-19-22(21)25-7-6-24-19;1-30-22-7-6-21(27-28-22)26-16-2-4-18(5-3-16)32-20-15-17(29-10-12-31-13-11-29)14-19-23(20)25-9-8-24-19/h6-7,13-16,18,20,22H,1-5,8-12,17H2,(H,29,30,31);7-8,13-15,17,19H,3-6,9-12H2,1-2H3,(H,27,31);6-9,14-16,18H,2-5,10-13H2,1H3,(H,26,30);6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,26,30)(H,27,28);6-9,14-16,18H,2-5,10-13H2,1H3,(H,26,27).
What are the key properties of 1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine?
1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine has a molecular weight of 2236.67 g/mol, XLogP of 14.20, 27 rotatable bonds, 6 hydrogen bond donors, and 41 hydrogen bond acceptors.
Where does this data come from?
All data for 1,5-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-3-amine;1-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrazole-3-carboxamide;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1H-pyrazole-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(oxolan-3-yl)pyrimidin-2-amine is sourced from PubChem (CID 157052115), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).